retatrutide phase 2 trial type 2 diabetes weight loss 2024 More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Retatrutide: A Triple Agonist Shaping

But for many people, clinical trials offer a different path: one thats supported, monitored, and focused on delivering better outcomes

Learn more: To view or add a comment, sign in The Hunter Serotonin Toxicity Criteria are a set of clinical decision rules used to diagnose serotonin toxicity, also known as serotonin syndrome

In a 2018 analysis of clinical trial data, several researchers working with Novo Nordisk, the drugmaker for Ozempic and Wegovy, found that the drugs were safe and effective in adults over age 65, but noted that older adults reported discontinuation due to gastrointestinal issues at a higher rate than younger participants did

Each plays a role in metabolic regulation, appetite control, and energy balance

More muscle translates into a higher resting metabolism, which is crucial for long-term weight management

Due to its multi-receptor engagement, Retatrutide has become a focus of interest in metabolic, endocrinological, and obesity-related research